# The Precision Hypertension Care Study

> **NCT02774460** · PHASE4 · COMPLETED · sponsor: **Uppsala University** · enrollment: 280 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Zestril®
- **DRUG:** Atacand®
- **DRUG:** Norvasc®
- **DRUG:** Hydrochlorthiazide®
- **DRUG:** Treatment X
- **DRUG:** Treatment Y
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02774460
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2021-06-11
- **Final completion:** 2021-06-11
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02774460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02774460, "The Precision Hypertension Care Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02774460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*